Physicians have been getting paid by drug and device manufacturers for years, with payments covering everything from speaking fees and lunches to research grants. However, the payments were largely hidden from public view until the Affordable Care Act’s Open Payments program debuted in 2014. The program recently reported data for 2016, and payments and transfers topped $8 billion, continuing an upward trajectory.
It’s not clear why the payments have increased over the last three years, but it might have to do with more accurate reporting, Katie Pawlitz, a health-care attorney with Reed Smith LLP, told me. “This could be the result of CMS and others continuing to educate the industry and public about Open Payments and to release guidance about the requirements,” Pawlitz said.
Payments and transfers exceeded $7 billion in each of the two most recent years previously reported, totaling $7.49 billion in 2014 and $7.52 billion in 2015.
The Open Payments program requires manufacturers of drugs, devices, and other medical supplies, along with group purchasing organizations, to report certain payments to physicians and teaching hospitals. The program is designed to prevent companies from using payments to physicians and hospitals as an incentive for them to prescribe or buy a company's products.
While the program is intended to help consumers choose their health-care providers, it’s unlikely that the average consumer is even aware of its existence or is actively using it, Danielle Sloane, a health-care attorney with Bass, Berry & Sims, told me.
At the same time, however, the data can be useful for hospitals and physician employers to track industry relationships with their physicians. The Centers for Medicare & Medicaid Services added some new features to the latest data, allowing users to compare a physician’s data with national and specialty data, as well as allowing for a review of payment data on a state level.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)